Early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury (The ELAIN-Trial): Study protocol for a randomized controlled trial

Trials

Volumn 17, Issue 1, 2016, Pages

  Zarbock, Alexander ^a   Gerß, Joachim ^a   Van Aken, Hugo ^a   Boanta, Andreea ^a   Kellum, John A ^b   Meersch, Melanie ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Clinical trial; Critically ill patients; Renal replacement therapy

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; CONVALESCENCE; CRITICALLY ILL PATIENT; DISEASE CLASSIFICATION; DISEASE SEVERITY; EARLY INTERVENTION; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SURVIVAL TIME; ACUTE KIDNEY INJURY; ADOLESCENT; ADVERSE EFFECTS; COMPARATIVE STUDY; CRITICAL ILLNESS; GERMANY; INTENTION TO TREAT ANALYSIS; KIDNEY; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; SURVIVAL ANALYSIS; TIME FACTOR; TIME TO TREATMENT; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL PROTOCOLS; CRITICAL ILLNESS; FEMALE; GERMANY; HUMANS; INTENTION TO TREAT ANALYSIS; KIDNEY; LENGTH OF STAY; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; RENAL REPLACEMENT THERAPY; RESEARCH DESIGN; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84961689528     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-016-1249-9     Document Type: Article

References (41)

1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813-8.
2. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ. Acute renal failure in intensive care units--causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med. 1996;24:192-8.
3. Ostermann M, Chang R. The RIFLE criteria: are the foundations robust? Crit Care Med. 2007;35:2669-70.
4. Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10:R73.
5. Bagshaw SM, George C, Bellomo R, Committe ADM. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2008;23:1569-74.
6. Kidney Disease: Improving Global Outcomes (KDIGO) Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1-138.
7. Gettings LG, Reynolds HN, Scalea T. Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late. Intensive Care Med. 1999;25:805-13.
8. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, et al. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care. 2009;24:129-40.
9. Shiao CC, Wu VC, Li WY, Lin YF, Hu FC, et al. Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery. Crit Care. 2009;13:R171.
10. Liu KD, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2006;1:915-9.
11. Jun M, Bellomo R, Cass A, Gallagher M, Lo S, et al. Timing of renal replacement therapy and patient outcomes in the randomized evaluation of normal versus augmented level of replacement therapy study. Crit Care Med. 2014;42:1756-65.
12. Pannu N, Klarenbach S, Wiebe N, Manns B, Tonelli M, et al. Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA. 2008;299:793-805.
13. Karvellas CJ, Farhat MR, Sajjad I, Mogensen SS, Leung AA, et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care. 2011;15:R72.
14. Seabra VF, Balk EM, Liangos O, Sosa MA, Cendoroglo M, et al. Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis. 2008;52:272-84.
15. Cruz DN, de Geus HR, Bagshaw SM. Biomarker strategies to predict need for renal replacement therapy in acute kidney injury. Semin Dial. 2011;24:124-31.
16. Srisawat N, Murugan R, Kellum JA. Repair or progression after AKI: a role for biomarkers? Nephron Clin Pract. 2014;127:185-9.
17. Clark WR, Letteri JJ, Uchino S, Bellomo R, Ronco C. Recent clinical advances in the management of critically ill patients with acute renal failure. Blood Purif. 2006;24:487-98.
18. Matson J, Zydney A, Honore PM. Blood filtration: new opportunities and the implications of systems biology. Crit Care Resusc. 2004;6:209-17.
19. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). E9. Statistical principles for clinical trials. Geneva: ICH; 1998.
20. Chou YH, Huang TM, Wu VC, Wang CY, Shiao CC, et al. Impact of timing of renal replacement therapy initiation on outcome of septic acute kidney injury. Crit Care. 2011;15:R134.
21. Elahi MM, Lim MY, Joseph RN, Dhannapuneni RR, Spyt TJ. Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure. Eur J Cardiothorac Surg. 2004;26:1027-31.
22. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med. 2002;30:2205-11.
23. Demirkilic U, Kuralay E, Yenicesu M, Caglar K, Oz BS, et al. Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg. 2004;19:17-20.
24. Sugahara S, Suzuki H. Early start on continuous hemodialysis therapy improves survival rate in patients with acute renal failure following coronary bypass surgery. Hemodial Int. 2004;8:320-5.
25. Wassmer G. Planning and analyzing adaptive group sequential survival trials. Biom J. 2006;48:714-29.
26. Lehmacher W, Wassmer G. Adaptive sample size calculations in group sequential trials. Biometrics. 1999;55:1286-90.
27. Muller HH, Schafer H. Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches. Biometrics. 2001;57:886-91.
28. Muller HH, Schafer H. A general statistical principle for changing a design any time during the course of a trial. Stat Med. 2004;23:2497-508.
29. Ricci Z, Ronco C, D'Amico G, De Felice R, Rossi S, et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant. 2006;21:690-6.
30. Macedo E, Malhotra R, Bouchard J, Wynn SK, Mehta RL. Oliguria is an early predictor of higher mortality in critically ill patients. Kidney Int. 2011;80:760-7.
31. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol. 2007;2:431-9.
32. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707-10.
33. Vanmassenhove J, Glorieux G, Lameire N, Hoste E, Dhondt A, et al. Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis. BMC Nephrol. 2015;16:18.
34. Otto GP, Hurtado-Oliveros J, Chung HY, Knoll K, Neumann T, et al. Plasma neutrophil gelatinase-associated lipocalin is primarily related to inflammation during sepsis: a translational approach. PLoS One. 2015;10:e0124429.
35. Cruz DN, de Cal M, Garzotto F, Perazella MA, Lentini P, et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med. 2010;36:444-51.
36. Ralib A, Pickering JW, Shaw GM, Than MP, George PM, et al. The clinical utility window for acute kidney injury biomarkers in the critically ill. Crit Care. 2014;18:601.
37. Nicoara A, Patel UD, Phillips-Bute BG, Shaw AD, Stafford-Smith M, et al. Mortality trends associated with acute renal failure requiring dialysis after CABG surgery in the United States. Blood Purif. 2009;28:359-63.
38. VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359:7-20.
39. Barbar SD, Binquet C, Monchi M, Bruyere R, Quenot JP. Impact on mortality of the timing of renal replacement therapy in patients with severe acute kidney injury in septic shock: the IDEAL-ICU study (initiation of dialysis early versus delayed in the intensive care unit): study protocol for a randomized controlled trial. Trials. 2014;15:270.
40. Haase M, Bellomo R, Devarajan P, Ma Q, Bennett MR, et al. Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Ann Thorac Surg. 2009;88:124-30.
41. Bagshaw SM, Bennett M, Haase M, Haase-Fielitz A, Egi M, et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med. 2010;36:452-61.